{"url_path":"/sec/cwan/8-k/2026-06-25/item-5-02","section_key":"item-5-02","section_title":"Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Arrangements of Certain Officers.","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-06-25","source_url":"https://www.sec.gov/Archives/edgar/data/1866368/0001193125-26-282050-index.html","accession_number":"0001193125-26-282050","cik":"0001866368","ticker":"CWAN","issuer_name":"Clearwater Analytics Holdings, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1866368/0001193125-26-282050-index.html","primary_entity_key":"0001866368","primary_entity_name":"Clearwater Analytics Holdings, Inc."},"word_count":189,"has_tables":true,"body_markdown":"Item 5.02\n\nDeparture of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Arrangements of Certain Officers.\n\nEffective upon the consummation of the Merger, each of Dr. Mukesh Aghi, Jacques Aigrain, Cary Davis, Christopher Hooper, Lisa Jones, Eric Lee, D. Scott Mackesy, Bas NieuweWeme and Andrew Young resigned from the Board and from any and all committees of the Board on which they served and ceased to be directors of the Company, and the directors of Merger Sub immediately prior to the Effective Time, Peter Flynn and Thomas Lafrance, were appointed as directors of the Company. Immediately thereafter, Parent, as the sole stockholder of the Company, removed all of the directors of the Company (other than Sandeep Sahai) and elected Jim Cox to serve as a director of the Company.\n\nIn addition, at the Effective Time, the Company terminated the Company’s 2021 Omnibus Incentive Plan, the Enfusion, Inc. 2021 Stock Option and Incentive Plan and the Company’s 2021 Employee Stock Purchase Plan.\n\nThe information in the Introductory Note and in Item 2.01 of this Current Report on Form 8-K is incorporated by reference into this Item 5.02."}